CAS NO: | 1607431-21-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Upadacitinib (ABT-494) tartrate tetrahydrate is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib tartrate tetrahydrate displays approximately 74 fold selective forJAK1overJAK2(200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib tartrate tetrahydrate can be used for several autoimmune disorders research[1][2]. | ||||||||
IC50& Target[1] |
| ||||||||
体外研究 (In Vitro) | In biochemical assays, Upadacitinib tartrate tetrahydrate is 74-fold more selective for JAK-1 than for JAK-2 (which is involved in erythropoiesis) and 58-fold more selective for JAK-1 than for JAK-3 (which is involved in immunosurveillance)[1]. | ||||||||
体内研究 (In Vivo) | Upadacitinib (0.1-10 mg/kg; oral gavage; twice a day for 10 days) tartrate tetrahydrate demonstrates efficacy in rat arthritis models[3].
| ||||||||
Clinical Trial | |||||||||
分子量 | 602.52 | ||||||||
Formula | C17H19F3N6O.C4H6O6.4H2O | ||||||||
CAS 号 | 1607431-21-9 | ||||||||
中文名称 | 乌帕替尼四水酒石酸盐 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |